A pertussis outbreak among daycare children in northern Israel: Who gets sick?

Israel Medical Association Journal

Volumn 12, Issue 5, 2010, Pages 283-286

  Hochwald, Ori ^a   Bamberger, Ellen S ^a   Rubin, Lisa ^a   Gershte, Rosa ^a   Srugo, Isaac ^a  

^a BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Bordetella pertussis; Outbreak; Polymerase chain reaction

Indexed keywords

AZITHROMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ANTIINFECTIVE AGENT; PERTUSSIS VACCINE;

ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DAY CARE; DRUG EFFICACY; EPIDEMIC; FOLLOW UP; HUMAN; INCIDENCE; ISRAEL; NOSE SMEAR; PERTUSSIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SYMPTOM; THROAT CULTURE; DISEASE OUTBREAKS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; WHOOPING COUGH;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHEMOPREVENTION; CHILD DAY CARE CENTERS; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FOLLOW-UP STUDIES; HUMANS; ISRAEL; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WHOOPING COUGH;

EID: 77953531882     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24(5): S10-18.
2. Klement E, Uliel L, Engel I, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003; 31(3): 1049-54.
3. Bisgard KM, Rhodes P, Connelly BL, et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005; 116(2): e285-94.
4. Central Bureau of Statistics of Israel. http:www.cbs.gov.il/sidfile.cgi.infectiousdiseases-pertussis, 2004.
5. Ministry of Health State of Israel. Notifiable infectious diseases in Israel (2004). 50 years of surveillance. 1951-2001. Publication No. 224 (http://www.health.gov.il/download/pages/zihumiyut20.pdf)
6. Moerman L, Leventhal A, Slater P, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. IMAJ Isr Med Assoc J 2006; 8: 308-11.
7. Rishpon S. Recent improvements in polio and pertussis vaccination policy in Israel, 2005. IMAJ Isr Med Assoc J 2006; 8: 319-21.
8. Rager B. Vaccines and vaccination programs revisited. IMAJ Isr Med Assoc J 2006; 8: 299-300.
9. Backman A, Johansson B, Olcen P. Nested PCR optimized for detection of Bordetella pertussis in clinical nasopharyngeal samples. J Clin Microbiol 1994; 32(10): 2544-8.
10. Lichtinghagen R, Diedrich-Glaubitz R, von Horsten B. Identification of Bordetella pertussis in nasopharyngeal swabs using a polymerase chain reaction: evaluation of detection methods. Eur J Clin Chem Clin Biochem 1994; 32(3): 161-7.
11. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev 2005: CD004404.
12. Langley JM, Halperin SA, Boucher FD, Smith B. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 2004; 114(1): e96-101.
13. NIP Publications. Guidelines for the Control of Pertussis Outbreaks. Available at http://www.cdc.gov/nip/publications/pertussis/guide.htm. CDC 2000; amendments made in 2005 and 2006
14. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002; 347(24): 1909-15.
15. Fisher MC, Long SS, McGowan KL, Kaselis E, Smith DG. Outbreak of pertussis in a residential facility for handicapped people. J Pediatr 1989; 114(6): 934-9.
16. Mink CA, Sirota NM, Nugent S. Outbreak of pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med 1994; 148(2): 153-7.
17. Kakar R, Mojadidi M, Mofleh J. Pertussis in Afghanistan, 2007-2008. Emerg Infect Dis 2009; 15(3): 501.
18. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997; 46(RR-7): 1-25.
19. Trollfors B, Taranger J, Lagergard T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995; 333(16): 1045-50.
20. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003; 21(17-18): 2003-14.
21. Schmitt HJ, von Konig CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996; 275(1): 37-41.
22. Khetsuriani N, Bisgard K, Prevots DR, et al. Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis 2001; 20(12): 1108-12.
23. Salmaso S, Mastrantonio P, Tozzi AE, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001; 108(5): E81.
24. Bamberger E, Srugo I. What is new in pertussis? Eur J Pediatr 2008; 167(2): 133-9.
25. South Yorkshire Health Protection Unit. Guidelines for chemoprophylaxis and immunization in persons exposed to pertussis. http://www.hpa.org.uk/infections/topics_az/whoopingcough/images/SYHPU_pertussis_guidelines.pdf. February 2005